Literature DB >> 22470070

Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to Plasma-Lyte.

Andrew D Shaw1, Sean M Bagshaw, Stuart L Goldstein, Lynette A Scherer, Michael Duan, Carol R Schermer, John A Kellum.   

Abstract

OBJECTIVE: To assess the association of 0.9% saline use versus a calcium-free physiologically balanced crystalloid solution with major morbidity and clinical resource use after abdominal surgery.
BACKGROUND: 0.9% saline, which results in a hyperchloremic acidosis after infusion, is frequently used to replace volume losses after major surgery.
METHODS: An observational study using the Premier Perspective Comparative Database was performed to evaluate adult patients undergoing major open abdominal surgery who received either 0.9% saline (30,994 patients) or a balanced crystalloid solution (926 patients) on the day of surgery. The primary outcome was major morbidity and secondary outcomes included minor complications and acidosis-related interventions. Outcomes were evaluated using multivariable logistic regression and propensity scoring models.
RESULTS: For the entire cohort, the in-hospital mortality was 5.6% in the saline group and 2.9% in the balanced group (P < 0.001). One or more major complications occurred in 33.7% of the saline group and 23% of the balanced group (P < 0.001). In the 3:1 propensity-matched sample, treatment with balanced fluid was associated with fewer complications (odds ratio 0.79; 95% confidence interval 0.66-0.97). Postoperative infection (P = 0.006), renal failure requiring dialysis (P < 0.001), blood transfusion (P < 0.001), electrolyte disturbance (P = 0.046), acidosis investigation (P < 0.001), and intervention (P = 0.02) were all more frequent in patients receiving 0.9% saline.
CONCLUSIONS: Among hospitals in the Premier Perspective Database, the use of a calcium-free balanced crystalloid for replacement of fluid losses on the day of major surgery was associated with less postoperative morbidity than 0.9% saline.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22470070     DOI: 10.1097/SLA.0b013e31825074f5

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  158 in total

1.  Learning curve assessment of robot-assisted radical prostatectomy compared with open-surgery controls from the premier perspective database.

Authors:  John W Davis; Usha S Kreaden; Jessica Gabbert; Raju Thomas
Journal:  J Endourol       Date:  2014-02-06       Impact factor: 2.942

2.  Chloride Content of Fluids Used for Large-Volume Resuscitation Is Associated With Reduced Survival.

Authors:  Ayan Sen; Christopher M Keener; Florentina E Sileanu; Emily Foldes; Gilles Clermont; Raghavan Murugan; John A Kellum
Journal:  Crit Care Med       Date:  2017-02       Impact factor: 7.598

3.  Use of Antihypertensive Medications and Uterotonics During Delivery Hospitalizations in Women With Asthma.

Authors:  Whitney A Booker; Zainab Siddiq; Yongmei Huang; Cande V Ananth; Jason D Wright; Kirsten L Cleary; Mary E DʼAlton; Alexander M Friedman
Journal:  Obstet Gynecol       Date:  2018-07       Impact factor: 7.661

Review 4.  "I don't get no respect": the role of chloride in acute kidney injury.

Authors:  Joshua L Rein; Steven G Coca
Journal:  Am J Physiol Renal Physiol       Date:  2018-12-12

5.  Resuscitation fluid use in Australian and New Zealand Intensive Care Units between 2007 and 2013.

Authors:  N E Hammond; C Taylor; M Saxena; B Liu; S Finfer; P Glass; I Seppelt; L Willenberg; J Myburgh
Journal:  Intensive Care Med       Date:  2015-06-03       Impact factor: 17.440

6.  Crystalloid fluid therapy: is the balance tipping towards balanced solutions?

Authors:  Paul J Young; Michael Joannidis
Journal:  Intensive Care Med       Date:  2014-11-11       Impact factor: 17.440

Review 7.  What's new in perioperative renal dysfunction?

Authors:  Johan Mårtensson; R Bellomo
Journal:  Intensive Care Med       Date:  2015-01-08       Impact factor: 17.440

Review 8.  New perioperative fluid and pharmacologic management protocol results in reduced blood loss, faster return of bowel function, and overall recovery.

Authors:  Patrick Y Wuethrich; Fiona C Burkhard
Journal:  Curr Urol Rep       Date:  2015-04       Impact factor: 3.092

Review 9.  Fluid therapy and outcome: balance is best.

Authors:  Sara J Allen
Journal:  J Extra Corpor Technol       Date:  2014-03

Review 10.  Fluid management for the prevention and attenuation of acute kidney injury.

Authors:  John R Prowle; Christopher J Kirwan; Rinaldo Bellomo
Journal:  Nat Rev Nephrol       Date:  2013-11-12       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.